# Combination Chemotherapy in Treating Patients With Solid Tumors

> **NCT00009932** · PHASE1 · UNKNOWN · sponsor: **Ohio State University Comprehensive Cancer Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fenretinide
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00009932
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00009932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00009932, "Combination Chemotherapy in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00009932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
